Curis Inc reports results for the quarter ended September 30 - Earnings Summary

Curis

14/11/2024 20:55

* Curis Inc  CRIS.OQ  reported a quarterly adjusted loss of
$1.70​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of $-2.13.  The mean expectation of six analysts for the quarter
was for a loss of $1.83 per share. Wall Street expected
results to range from $-2.11 to $-1.62 per share.
    * Revenue rose 3.5% to $2.93 million from a year ago;
analysts
expected $2.28 million. 
    * Curis Inc's reported EPS for the quarter was a loss of
$1.70​.
    * The company reported a quarterly loss of $10.09 million.
    * Curis Inc shares had fallen by 27.1% this quarter and
lost 69.2%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 3.4%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Curis Inc is
20.00 
This summary was machine generated from LSEG data November 14 at
08:55 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -1.83          -1.70          Beat
 Jun. 30 2024      -1.67          -2.03          Missed
 Mar. 31 2024      -2.12          -2.05          Beat
 Dec. 31 2023      -2.11          -2.03          Beat